Leonard Mazur CEO Of Citius Pharmasuticals
www.danayaazure.com
https://citiuspharma.com/
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products. LYMPHIR™ (denileukin diftitox-cxdl), our targeted immune therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL) is now approved by the FDA. Commercialization efforts are underway to make this therapy available to patients.
Our team’s extensive experience in the pharmaceutical industry allows us to identify compelling opportunities and develop assets that have unique commercial advantages and differentiated upside potential. By deploying capital thoughtfully, we believe our activities will provide patients and caregivers with improved treatment options and deliver long-term sustainable value to shareholders.
Popular Podcasts
Las Culturistas with Matt Rogers and Bowen Yang
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.